FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

35392311000001103: Lisinopril 20mg tablets (Crescent Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-May 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
107007801000001118 Lisinopril 20mg tablets (Crescent Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
107007901000001112 Lisinopril 20mg tablets (Crescent Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lisinopril 20mg tablets (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lisinopril 20mg tablets (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lisinopril 20mg tablets (Crescent Pharma Ltd) Is a Product containing precisely lisinopril 20 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Lisinopril 20mg tablets (Crescent Pharma Ltd) Has active ingredient Lisinopril false Inferred relationship Existential restriction modifier 1
Lisinopril 20mg tablets (Crescent Pharma Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Lisinopril 20mg tablets (Crescent Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Lisinopril 20mg tablets (Crescent Pharma Ltd) Has basis of strength substance Lisinopril true Inferred relationship Existential restriction modifier 1
Lisinopril 20mg tablets (Crescent Pharma Ltd) Has presentation strength numerator value 20 false Inferred relationship Existential restriction modifier 1
Lisinopril 20mg tablets (Crescent Pharma Ltd) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Lisinopril 20mg tablets (Crescent Pharma Ltd) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Lisinopril 20mg tablets (Crescent Pharma Ltd) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Lisinopril 20mg tablets (Crescent Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lisinopril 20mg tablets (Crescent Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lisinopril 20mg tablets (Crescent Pharma Ltd) Has specific active ingredient Lisinopril true Inferred relationship Existential restriction modifier
Lisinopril 20mg tablets (Crescent Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lisinopril 20mg tablets (Crescent Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lisinopril 20mg tablets (Crescent Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lisinopril 20mg tablets (Crescent Pharma Ltd) 28 tablet 2 x 14 tablets Has AMP True Lisinopril 20mg tablets (Crescent Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start